Jens Kuhlmann

796 total citations
13 papers, 585 citations indexed

About

Jens Kuhlmann is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Jens Kuhlmann has authored 13 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 4 papers in Molecular Biology and 3 papers in Nephrology. Recurrent topics in Jens Kuhlmann's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Antimicrobial Peptides and Activities (3 papers). Jens Kuhlmann is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Antimicrobial Peptides and Activities (3 papers). Jens Kuhlmann collaborates with scholars based in Germany, Netherlands and Switzerland. Jens Kuhlmann's co-authors include Anton Hagenbeek, Franck Morschhauser, A. Z. S. Rohatiner, Pierre Soubeyran, Peter C. Huijgens, Hervé Tilly, Wim van Putten, Pier Luigi Zinzani, Umberto Vitolo and John Radford and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Jens Kuhlmann

13 papers receiving 573 citations

Peers

Jens Kuhlmann
Joo-Seop Chung South Korea
Mike Leach United Kingdom
Monika Długosz‐Danecka Poland
Teresa Amato Italy
László Váróczy Hungary
Sven Borchmann Germany
Filiz Şen United States
F. B. Hagemeister United States
Daniel Tsai United States
Miles Prince Australia
Joo-Seop Chung South Korea
Jens Kuhlmann
Citations per year, relative to Jens Kuhlmann Jens Kuhlmann (= 1×) peers Joo-Seop Chung

Countries citing papers authored by Jens Kuhlmann

Since Specialization
Citations

This map shows the geographic impact of Jens Kuhlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Kuhlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Kuhlmann more than expected).

Fields of papers citing papers by Jens Kuhlmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Kuhlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Kuhlmann. The network helps show where Jens Kuhlmann may publish in the future.

Co-authorship network of co-authors of Jens Kuhlmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Kuhlmann. A scholar is included among the top collaborators of Jens Kuhlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Kuhlmann. Jens Kuhlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Homburg, Ursula, Harald Renz, Wolfgang Timmer, et al.. (2015). Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma. Journal of Allergy and Clinical Immunology. 136(3). 797–800. 38 indexed citations
2.
Homburg, Ursula, Agnieszka Turowska, Jens Kuhlmann, et al.. (2013). Safety profile and pharmacokinetics of SB010, an inhaled GATA-3-specific DNAzyme, in phase I clinical trials in healthy and asthmatic subjects. European Respiratory Journal. 42(Suppl 57). 4858–4858. 2 indexed citations
3.
Turowska, Agnieszka, Damiano Librizzi, Jens Kuhlmann, et al.. (2013). Biodistribution of the GATA-3-specific DNAzyme hgd40 after inhalative exposure in mice, rats and dogs. Toxicology and Applied Pharmacology. 272(2). 365–372. 18 indexed citations
4.
Schmidts, Thomas, et al.. (2011). Skin hydration and cooling effect produced by the Voltaren® vehicle gel. Skin Research and Technology. 18(2). 199–206. 8 indexed citations
5.
Goff, Lindsey K., Karin E. Summers, Sameena Iqbal, et al.. (2009). Quantitative PCR Analysis for Bcl-2/IgH in a Phase III Study of Yttrium-90 Ibritumomab Tiuxetan As Consolidation of First Remission in Patients With Follicular Lymphoma. Journal of Clinical Oncology. 27(36). 6094–6100. 29 indexed citations
6.
7.
Morschhauser, Franck, John Radford, Achiel Van Hoof, et al.. (2008). Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma. Journal of Clinical Oncology. 26(32). 5156–5164. 314 indexed citations
8.
Elter, Thomas, István Molnár, Jens Kuhlmann, Michael Hallek, & Clemens‐Martin Wendtner. (2008). Pharmacokinetics of alemtuzumab and the relevance in clinical practice. Leukemia & lymphoma. 49(12). 2256–2262. 33 indexed citations
9.
10.
Mould, Diane R., Andreas Baumann, Jens Kuhlmann, et al.. (2007). Population pharmacokinetics–pharmacodynamics of alemtuzumab (Campath®) in patients with chronic lymphocytic leukaemia and its link to treatment response. British Journal of Clinical Pharmacology. 64(3). 278–291. 92 indexed citations
11.
12.
Dobos, G., Markus Bürger, Jens Kuhlmann, et al.. (1997). Improved cytosolic free calcium mobilization and superoxide production in bicarbonate-based peritoneal dialysis solution. Nephrology Dialysis Transplantation. 12(5). 973–977. 6 indexed citations
13.
Dobos, Gustav, Joachim Böhler, Jens Kuhlmann, et al.. (1994). Bicarbona Te-Based Dialysis Solution Preserves Granulocyte Functions. Peritoneal Dialysis International. 14(4). 366–370. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joo-Seop Chung Breakdown of academic impact, for papers by Mike Leach Breakdown of academic impact, for papers by Monika Długosz‐Danecka Breakdown of academic impact, for papers by Teresa Amato Breakdown of academic impact, for papers by László Váróczy Breakdown of academic impact, for papers by Sven Borchmann Breakdown of academic impact, for papers by Filiz Şen Breakdown of academic impact, for papers by F. B. Hagemeister Breakdown of academic impact, for papers by Daniel Tsai Breakdown of academic impact, for papers by Miles Prince
Rankless by CCL
2026